Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Journal of Gastroenterology
Published in: Clinical Journal of Gastroenterology 4/2017

01-08-2017 | Case Report

Uptake of 123I-metaiodobenzylguanidine by gastrointestinal stromal tumor

Authors: Patommatat Bhanthumkomol, Susumu Hijioka, Nobumasa Mizuno, Takamichi Kuwahara, Nozomi Okuno, Ayako Ito, Tsutomu Tanaka, Makoto Ishihara, Yutaka Hirayama, Sachiyo Onishi, Yasumasa Niwa, Masahiro Tajika, Yuichi Ito, Eiichi Sasaki, Yoshitaka Inaba, Yasuhiro Shimizu, Yasushi Yatabe, Kazuo Hara

Published in: Clinical Journal of Gastroenterology | Issue 4/2017

Login to get access

Abstract

A 52-year-old woman was admitted with a large intraabdominal mass. 123I- metaiodobenzylguanidine (123I-MIBG) scintigraphy revealed considerable 123I-MIBG accumulation by the mass that was compatible with a diagnosis of paraganglioma. However, a spindle cell tumor that was identified using endoscopic ultrasound-guided fine needle aspiration before surgery was positive for CD117. The surgically resected mass was confirmed as a gastrointestinal stromal tumor (GIST). Although the mechanism of 123I-MIBG uptake by GIST has not been elucidated, GIST should be included in the differential diagnosis of intra-abdominal tumor with 123I-MIBG uptake.
Literature
1.
Shapiro B. Summary, conclusions, and future directions of [131I]metaiodobenzylguanidine therapy in the treatment of neural crest tumors. J Nucl Biol Med. 1991;35(4):357–63.PubMed
2.
Ilias I, Pacak K. Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab. 2004;89(2):479–91.CrossRefPubMed
3.
Sone H, Okuda Y, Nakamura Y, et al. Radioiodinated metaiodobenzylguanidine scintigraphy for pheochromocytoma. A false-positive case of adrenocortical adenoma and literature review. Horm Res. 1996;46:138–42.CrossRefPubMed
4.
Rainis T, Ben-Haim S, Dickstein G. False positive metaiodobenzylguanidine scan in a patient with a huge adrenocortical carcinoma. J Clin Endocrinol Metab. 2000;85:5–7.CrossRefPubMed
5.
Jung HS, Moon SJ, Kim YM, et al. False positive radioiodinated metaiodobenzylguanidine ((123)I-MIBG) uptake in undifferentiated adrenal malignant tumor. Case Rep Oncol Med. 2015;2015:164280.PubMedPubMedCentral
6.
Inoue Y, Akahane M, Kitazawa T, et al. False positive uptake of metaiodobenzylguanidine in hepatocellular carcinoma. Br J Radiol. 2002;75:548–51.CrossRefPubMed
7.
Kume H, Nishimura S, Teramoto S, et al. An [123 I]MIBG-positive malignant lymphoma involving the adrenal gland with hypercatecholaminaemia. Clin Radiol. 2008;6:475–7.CrossRef
8.
Rottenburger C, Juettner E, Harttrampf AC, et al. False-positive radio-iodinated metaiodobenzylguanidine (123I-MIBG) accumulation in a mast cell-infiltrated infantile haemangioma. Br J Radiol. 2010;83:e168–71.CrossRefPubMedPubMedCentral
9.
Kubota K, Kato S, Mawatari H, et al. Risky endoscopic ultrasonography-guided fine-needle aspiration for asymptomatic retroperitoneal tumors. Dig Endosc. 2010;22:144–6.CrossRefPubMed
10.
Demetri GD, von Mehren M, Antonescu CR, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw. 2010;8(Suppl 2):S1–41.CrossRefPubMedPubMedCentral
11.
Jacobson AF, Deng H, Lombard J, et al. 123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis. J Clin Endocrinol Metab. 2010;95:2596–606.CrossRefPubMed
12.
Kindblom LG, Remotti HE, Aldenborg F, et al. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998;152:1259–69.PubMedPubMedCentral
13.
Sircar K, Hewlett BR, Huizinga JD, et al. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol. 1999;23:377–89.CrossRefPubMed
14.
Terada T. Smooth muscles and stem cells of embryonic guts express KIT, PDGFRA, CD34 and many other stem cell antigens: Suggestion that GIST arise from smooth muscles and gut stem cells. Int J Clin Exp Pathol. 2013;6:1038–45.PubMedPubMedCentral
15.
Balan KK, Sonoda LI, Pawaroo D. I-123 MIBG uptake in a gastrointestinal stromal tumor (GIST). Clin Nucl Med. 2010;35:196–7.CrossRefPubMed
16.
Fukuchi K, Suzuki M, Sato S, et al. Unusually increased metaiodobenzylguanidine uptake in a gastrointestinal stromal tumor of the stomach. Ann Nucl Med. 2012;26:684–7.CrossRefPubMed
17.
van Dellen D, Mitu-Pretorian OM, Augustine T. Aberrant I-123 MIBG uptake in a gastrointestinal stromal tumour. Updat Surg. 2013;65:71–6.CrossRef
18.
Harb A, Forster J, Damjanov I. Gastrointestinal autonomic nerve tumor secreting catecholamines. Virchows Arch. 2005;447:892–3.CrossRefPubMed
19.
Meshikhes AW, Al-Momen SA. Gastrointestinal autonomic nerve tumors: a clinical review. J Gastrointest Surg. 2015;19:1144–56.CrossRefPubMed
20.
Bayer M, Kuci Z, Schomig E, Grundemann D, Dittmann H, Handgretinger R, et al. Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells. Nucl Med Biol. 2009;36:287–94.CrossRefPubMed
Metadata
Title
Uptake of 123I-metaiodobenzylguanidine by gastrointestinal stromal tumor
Authors
Patommatat Bhanthumkomol
Susumu Hijioka
Nobumasa Mizuno
Takamichi Kuwahara
Nozomi Okuno
Ayako Ito
Tsutomu Tanaka
Makoto Ishihara
Yutaka Hirayama
Sachiyo Onishi
Yasumasa Niwa
Masahiro Tajika
Yuichi Ito
Eiichi Sasaki
Yoshitaka Inaba
Yasuhiro Shimizu
Yasushi Yatabe
Kazuo Hara
Publication date
01-08-2017
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 4/2017
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-017-0743-2

Other articles of this Issue 4/2017

Clinical Journal of Gastroenterology 4/2017 Go to the issue

Case Report

A case of protein-losing enteropathy caused by sclerosing mesenteritis diagnosed with capsule endoscopy and double-balloon endoscopy

Clinical Review

Laparoscopic cholecystectomy for cholelithiasis in children with sickle cell disease

Case Report

A case of malignant peritoneal mesothelioma suggesting the utility of combining double-contrast radiography and endoscopy with computed tomography for diagnosis

Clinical Review

The endoscopic findings of the upper gastrointestinal tract in patients with Crohn’s disease

Case Report

Narrow-band imaging can increase the visibility of fibrin caps after bleeding of esophageal varices: a case with extensive esophageal candidiasis

Case Report

A case of diminished pericardial effusion after treatment of a giant hepatic cyst

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits